Pharmstandard Ventures

Investor type

CVC

Founded

-

AUM

-

Location

Russia

Investment Ticket

$1-5 m

Investment Stage

Series A

Region of investment

North America South America Europe Middle East Africa Asia Australia and others
Investor profile last updated: 11 August, 2021

Profile

Pharmstandard Ventures is a Venture Arm within Pharmstandard, JSC, Russia's leading pharmaceutical company.
We were formed in 2013 as Inbio Ventures, and changed our name to Pharmstandard Ventures after corporate restructuring in 2017.

Industry

Biotechnology Healthcare Services Pharmaceuticals MedTech HealthTech

Contacts

Name
Title
Email
avatar
Elena Starikova Acting Head
Acting Head
-
avatar
Vadim Gorbunov Investment Manager
Investment Manager
-
Upgrade to see contacts
avatar
aCUdbeoTr790c5G4 aCUdbeoTr790c5G4
aCUdbeoTr790c5G4
avatar
aCUdbeoTr790c5G4 aCUdbeoTr790c5G4
aCUdbeoTr790c5G4
avatar
aCUdbeoTr790c5G4 aCUdbeoTr790c5G4
aCUdbeoTr790c5G4
Investment-team contacts for Pharmstandard Ventures — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Pharmstandard Ventures

Pharmstandard Ventures operates as a corporate VC (CVC). It backs companies at Series A, writing tickets of $1-5 m.
Pharmstandard Ventures is located in Russia.
Pharmstandard Ventures was founded in .
Pharmstandard Ventures invests in companies and startups in Biotechnology, Healthcare Services, Pharmaceuticals, MedTech, HealthTech.
Pharmstandard Ventures invests in companies and startups in North America, South America, Europe, Middle East, Africa, Asia, Australia and others.
Pharmstandard Ventures invests in companies and startups at Series A.
Pharmstandard Ventures usually invests $1-5 m on average.
Pharmstandard Ventures can be reached through its website pharmstd-ventures.com. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Pharmstandard Ventures — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Pharmstandard Ventures directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 11 August, 2021. Something out of date here? Report it — we re-run that firm within 48h and get back to you.